Clinical Trials

New Immune Discovery May Reverse Type 2 Diabetes
Research & Development New Immune Discovery May Reverse Type 2 Diabetes

A groundbreaking study from the University of Pittsburgh School of Medicine has illuminated a previously unknown immunological pathway that could fundamentally change how type 2 diabetes is treated, potentially offering a way to reverse the condition. As millions grapple with this chronic disease,

Is This the Next Breakthrough in Liver Cancer?
Research & Development Is This the Next Breakthrough in Liver Cancer?

For patients diagnosed with inoperable liver tumors, treatment options have often been limited, presenting a formidable challenge for both individuals and their medical teams. A new clinical trial, however, is offering a ray of hope by pioneering a therapy that brings the entire treatment

AI Predicts Optimal Timing for Critical ALS Surgery
Tech & Innovation AI Predicts Optimal Timing for Critical ALS Surgery

In the landscape of neurodegenerative diseases, the battle is often fought against uncertainty as much as the condition itself. For those living with Motor Neurone Disease (MND), the unpredictable progression can make planning for critical interventions, like the placement of a feeding tube, an

Can AI Revolutionize Alzheimer's Drug Discovery?
Research & Development Can AI Revolutionize Alzheimer's Drug Discovery?

For decades, the path to finding effective treatments for Alzheimer's disease has been fraught with frustratingly slow progress and a high rate of clinical failures, leaving millions of patients and their families with limited options. This long and challenging journey, however, is now reaching a

New Therapy Targets an Internal Immune System Brake
Research & Development New Therapy Targets an Internal Immune System Brake

In a landmark development for the field of oncology, cancer researchers have uncovered a crucial molecular switch that has long been hampering the immune system's capacity to effectively fight tumors, presenting a new avenue of hope for countless patients who find no benefit in existing

Researchers Target Aging to Fight Parkinson's Disease
Research & Development Researchers Target Aging to Fight Parkinson's Disease

The single greatest risk factor for developing Parkinson's disease has been systematically overlooked in the very laboratories dedicated to finding a cure, a baffling disconnect that a global consortium of scientists is now moving urgently to correct. For decades, the relentless march toward

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later